The global ROCK2 Inhibitor market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Netarsudil Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of ROCK2 Inhibitor include Kowa Pharmaceuticals, Senju Pharmaceutical, Novartis, AERIE PHARMACEUTICALS and Redx Pharma, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Rho-kinase inhibitors (rho-associated protein kinase inhibitor or ROCK inhibitor) are?a series of compounds that target rho kinase (ROCK) and inhibit the ROCK pathway
This report aims to provide a comprehensive presentation of the global market for ROCK2 Inhibitor, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding ROCK2 Inhibitor. This report contains market size and forecasts of ROCK2 Inhibitor in global, including the following market information:
- Global ROCK2 Inhibitor Market Revenue, 2019-2024, 2025-2030, ($ millions)
- Global top five companies in 2023 (%)
We surveyed the ROCK2 Inhibitor companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global ROCK2 Inhibitor Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global ROCK2 Inhibitor Market Segment Percentages, by Type, 2023 (%)
- Netarsudil
- Ripasudil Hydrochloride Hydrate
- Fasudil
- Others
Global ROCK2 Inhibitor Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global ROCK2 Inhibitor Market Segment Percentages, by Application, 2023 (%)
- Cerebral Vasospasm
- Glaucoma
- Others
Global ROCK2 Inhibitor Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global ROCK2 Inhibitor Market Segment Percentages, By Region and Country, 2023 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies ROCK2 Inhibitor revenues in global market, 2019-2024 (estimated), ($ millions)
- Key companies ROCK2 Inhibitor revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Kowa Pharmaceuticals
- Senju Pharmaceutical
- Novartis
- AERIE PHARMACEUTICALS
- Redx Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of ROCK2 Inhibitor, market overview.
Chapter 2: Global ROCK2 Inhibitor market size in revenue.
Chapter 3: Detailed analysis of ROCK2 Inhibitor company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of ROCK2 Inhibitor in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 ROCK2 Inhibitor Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global ROCK2 Inhibitor Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global ROCK2 Inhibitor Overall Market Size
2.1 Global ROCK2 Inhibitor Market Size: 2023 VS 2030
2.2 Global ROCK2 Inhibitor Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top ROCK2 Inhibitor Players in Global Market
3.2 Top Global ROCK2 Inhibitor Companies Ranked by Revenue
3.3 Global ROCK2 Inhibitor Revenue by Companies
3.4 Top 3 and Top 5 ROCK2 Inhibitor Companies in Global Market, by Revenue in 2023
3.5 Global Companies ROCK2 Inhibitor Product Type
3.6 Tier 1, Tier 2 and Tier 3 ROCK2 Inhibitor Players in Global Market
3.6.1 List of Global Tier 1 ROCK2 Inhibitor Companies
3.6.2 List of Global Tier 2 and Tier 3 ROCK2 Inhibitor Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global ROCK2 Inhibitor Market Size Markets, 2023 & 2030
4.1.2 Netarsudil
4.1.3 Ripasudil Hydrochloride Hydrate
4.1.4 Fasudil
4.1.5 Others
4.2 By Type - Global ROCK2 Inhibitor Revenue & Forecasts
4.2.1 By Type - Global ROCK2 Inhibitor Revenue, 2019-2024
4.2.2 By Type - Global ROCK2 Inhibitor Revenue, 2025-2030
4.2.3 By Type - Global ROCK2 Inhibitor Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global ROCK2 Inhibitor Market Size, 2023 & 2030
5.1.2 Cerebral Vasospasm
5.1.3 Glaucoma
5.1.4 Others
5.2 By Application - Global ROCK2 Inhibitor Revenue & Forecasts
5.2.1 By Application - Global ROCK2 Inhibitor Revenue, 2019-2024
5.2.2 By Application - Global ROCK2 Inhibitor Revenue, 2025-2030
5.2.3 By Application - Global ROCK2 Inhibitor Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global ROCK2 Inhibitor Market Size, 2023 & 2030
6.2 By Region - Global ROCK2 Inhibitor Revenue & Forecasts
6.2.1 By Region - Global ROCK2 Inhibitor Revenue, 2019-2024
6.2.2 By Region - Global ROCK2 Inhibitor Revenue, 2025-2030
6.2.3 By Region - Global ROCK2 Inhibitor Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America ROCK2 Inhibitor Revenue, 2019-2030
6.3.2 US ROCK2 Inhibitor Market Size, 2019-2030
6.3.3 Canada ROCK2 Inhibitor Market Size, 2019-2030
6.3.4 Mexico ROCK2 Inhibitor Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe ROCK2 Inhibitor Revenue, 2019-2030
6.4.2 Germany ROCK2 Inhibitor Market Size, 2019-2030
6.4.3 France ROCK2 Inhibitor Market Size, 2019-2030
6.4.4 U.K. ROCK2 Inhibitor Market Size, 2019-2030
6.4.5 Italy ROCK2 Inhibitor Market Size, 2019-2030
6.4.6 Russia ROCK2 Inhibitor Market Size, 2019-2030
6.4.7 Nordic Countries ROCK2 Inhibitor Market Size, 2019-2030
6.4.8 Benelux ROCK2 Inhibitor Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia ROCK2 Inhibitor Revenue, 2019-2030
6.5.2 China ROCK2 Inhibitor Market Size, 2019-2030
6.5.3 Japan ROCK2 Inhibitor Market Size, 2019-2030
6.5.4 South Korea ROCK2 Inhibitor Market Size, 2019-2030
6.5.5 Southeast Asia ROCK2 Inhibitor Market Size, 2019-2030
6.5.6 India ROCK2 Inhibitor Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America ROCK2 Inhibitor Revenue, 2019-2030
6.6.2 Brazil ROCK2 Inhibitor Market Size, 2019-2030
6.6.3 Argentina ROCK2 Inhibitor Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa ROCK2 Inhibitor Revenue, 2019-2030
6.7.2 Turkey ROCK2 Inhibitor Market Size, 2019-2030
6.7.3 Israel ROCK2 Inhibitor Market Size, 2019-2030
6.7.4 Saudi Arabia ROCK2 Inhibitor Market Size, 2019-2030
6.7.5 UAE ROCK2 Inhibitor Market Size, 2019-2030
7 ROCK2 Inhibitor Companies Profiles
7.1 Kowa Pharmaceuticals
7.1.1 Kowa Pharmaceuticals Company Summary
7.1.2 Kowa Pharmaceuticals Business Overview
7.1.3 Kowa Pharmaceuticals ROCK2 Inhibitor Major Product Offerings
7.1.4 Kowa Pharmaceuticals ROCK2 Inhibitor Revenue in Global Market (2019-2024)
7.1.5 Kowa Pharmaceuticals Key News & Latest Developments
7.2 Senju Pharmaceutical
7.2.1 Senju Pharmaceutical Company Summary
7.2.2 Senju Pharmaceutical Business Overview
7.2.3 Senju Pharmaceutical ROCK2 Inhibitor Major Product Offerings
7.2.4 Senju Pharmaceutical ROCK2 Inhibitor Revenue in Global Market (2019-2024)
7.2.5 Senju Pharmaceutical Key News & Latest Developments
7.3 Novartis
7.3.1 Novartis Company Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis ROCK2 Inhibitor Major Product Offerings
7.3.4 Novartis ROCK2 Inhibitor Revenue in Global Market (2019-2024)
7.3.5 Novartis Key News & Latest Developments
7.4 AERIE PHARMACEUTICALS
7.4.1 AERIE PHARMACEUTICALS Company Summary
7.4.2 AERIE PHARMACEUTICALS Business Overview
7.4.3 AERIE PHARMACEUTICALS ROCK2 Inhibitor Major Product Offerings
7.4.4 AERIE PHARMACEUTICALS ROCK2 Inhibitor Revenue in Global Market (2019-2024)
7.4.5 AERIE PHARMACEUTICALS Key News & Latest Developments
7.5 Redx Pharma
7.5.1 Redx Pharma Company Summary
7.5.2 Redx Pharma Business Overview
7.5.3 Redx Pharma ROCK2 Inhibitor Major Product Offerings
7.5.4 Redx Pharma ROCK2 Inhibitor Revenue in Global Market (2019-2024)
7.5.5 Redx Pharma Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. ROCK2 Inhibitor Market Opportunities & Trends in Global Market
Table 2. ROCK2 Inhibitor Market Drivers in Global Market
Table 3. ROCK2 Inhibitor Market Restraints in Global Market
Table 4. Key Players of ROCK2 Inhibitor in Global Market
Table 5. Top ROCK2 Inhibitor Players in Global Market, Ranking by Revenue (2023)
Table 6. Global ROCK2 Inhibitor Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global ROCK2 Inhibitor Revenue Share by Companies, 2019-2024
Table 8. Global Companies ROCK2 Inhibitor Product Type
Table 9. List of Global Tier 1 ROCK2 Inhibitor Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 ROCK2 Inhibitor Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global ROCK2 Inhibitor Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - ROCK2 Inhibitor Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - ROCK2 Inhibitor Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global ROCK2 Inhibitor Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - ROCK2 Inhibitor Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - ROCK2 Inhibitor Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global ROCK2 Inhibitor Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global ROCK2 Inhibitor Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global ROCK2 Inhibitor Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America ROCK2 Inhibitor Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America ROCK2 Inhibitor Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe ROCK2 Inhibitor Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe ROCK2 Inhibitor Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia ROCK2 Inhibitor Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia ROCK2 Inhibitor Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America ROCK2 Inhibitor Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America ROCK2 Inhibitor Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa ROCK2 Inhibitor Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa ROCK2 Inhibitor Revenue, (US$, Mn), 2025-2030
Table 30. Kowa Pharmaceuticals Company Summary
Table 31. Kowa Pharmaceuticals ROCK2 Inhibitor Product Offerings
Table 32. Kowa Pharmaceuticals ROCK2 Inhibitor Revenue (US$, Mn) & (2019-2024)
Table 33. Kowa Pharmaceuticals Key News & Latest Developments
Table 34. Senju Pharmaceutical Company Summary
Table 35. Senju Pharmaceutical ROCK2 Inhibitor Product Offerings
Table 36. Senju Pharmaceutical ROCK2 Inhibitor Revenue (US$, Mn) & (2019-2024)
Table 37. Senju Pharmaceutical Key News & Latest Developments
Table 38. Novartis Company Summary
Table 39. Novartis ROCK2 Inhibitor Product Offerings
Table 40. Novartis ROCK2 Inhibitor Revenue (US$, Mn) & (2019-2024)
Table 41. Novartis Key News & Latest Developments
Table 42. AERIE PHARMACEUTICALS Company Summary
Table 43. AERIE PHARMACEUTICALS ROCK2 Inhibitor Product Offerings
Table 44. AERIE PHARMACEUTICALS ROCK2 Inhibitor Revenue (US$, Mn) & (2019-2024)
Table 45. AERIE PHARMACEUTICALS Key News & Latest Developments
Table 46. Redx Pharma Company Summary
Table 47. Redx Pharma ROCK2 Inhibitor Product Offerings
Table 48. Redx Pharma ROCK2 Inhibitor Revenue (US$, Mn) & (2019-2024)
Table 49. Redx Pharma Key News & Latest Developments
List of Figures
Figure 1. ROCK2 Inhibitor Segment by Type in 2023
Figure 2. ROCK2 Inhibitor Segment by Application in 2023
Figure 3. Global ROCK2 Inhibitor Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global ROCK2 Inhibitor Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global ROCK2 Inhibitor Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by ROCK2 Inhibitor Revenue in 2023
Figure 8. By Type - Global ROCK2 Inhibitor Revenue Market Share, 2019-2030
Figure 9. By Application - Global ROCK2 Inhibitor Revenue Market Share, 2019-2030
Figure 10. By Type - Global ROCK2 Inhibitor Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global ROCK2 Inhibitor Revenue Market Share, 2019-2030
Figure 12. By Application - Global ROCK2 Inhibitor Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global ROCK2 Inhibitor Revenue Market Share, 2019-2030
Figure 14. By Region - Global ROCK2 Inhibitor Revenue Market Share, 2019-2030
Figure 15. By Country - North America ROCK2 Inhibitor Revenue Market Share, 2019-2030
Figure 16. US ROCK2 Inhibitor Revenue, (US$, Mn), 2019-2030
Figure 17. Canada ROCK2 Inhibitor Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico ROCK2 Inhibitor Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe ROCK2 Inhibitor Revenue Market Share, 2019-2030
Figure 20. Germany ROCK2 Inhibitor Revenue, (US$, Mn), 2019-2030
Figure 21. France ROCK2 Inhibitor Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. ROCK2 Inhibitor Revenue, (US$, Mn), 2019-2030
Figure 23. Italy ROCK2 Inhibitor Revenue, (US$, Mn), 2019-2030
Figure 24. Russia ROCK2 Inhibitor Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries ROCK2 Inhibitor Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux ROCK2 Inhibitor Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia ROCK2 Inhibitor Revenue Market Share, 2019-2030
Figure 28. China ROCK2 Inhibitor Revenue, (US$, Mn), 2019-2030
Figure 29. Japan ROCK2 Inhibitor Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea ROCK2 Inhibitor Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia ROCK2 Inhibitor Revenue, (US$, Mn), 2019-2030
Figure 32. India ROCK2 Inhibitor Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America ROCK2 Inhibitor Revenue Market Share, 2019-2030
Figure 34. Brazil ROCK2 Inhibitor Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina ROCK2 Inhibitor Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa ROCK2 Inhibitor Revenue Market Share, 2019-2030
Figure 37. Turkey ROCK2 Inhibitor Revenue, (US$, Mn), 2019-2030
Figure 38. Israel ROCK2 Inhibitor Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia ROCK2 Inhibitor Revenue, (US$, Mn), 2019-2030
Figure 40. UAE ROCK2 Inhibitor Revenue, (US$, Mn), 2019-2030
Figure 41. Kowa Pharmaceuticals ROCK2 Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Senju Pharmaceutical ROCK2 Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Novartis ROCK2 Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. AERIE PHARMACEUTICALS ROCK2 Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Redx Pharma ROCK2 Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
